Over time, this expanding dataset is likely to increase awareness and confidence in the therapies, helping to address residual concerns around side effects
It will be secured by investing in the professionals who prevent patients from needing a hospital bed in the first place
Targets slow weight loss to approximately 0.5 to 1.0 percent of body weight per week
A simple liver enzyme panel screen can alert a practitioner to the need for a deeper dive into diagnostic procedures such as an ultrasound, which is used to confirm the NAFLD diagnosis
Its contribution to NAION risk may actually exceed that of semaglutide in many patients
Bahuon, F., Pantazoglou, E., Untracht, G., Andersen, P